Genmab — Marts 2020
-
Vi husker hvad der skete med ofa da stoffet forsøgte sig imod Rituxan. Endelig er dara-sc også en fordel. Så jeg kunne godt tvivle på, at der bliver en væsentlig konkurrent, idet isa ikke har vist sig bedre end dara. Jeg er derimod mere obs på Takedas nye produkter.
-
Genmab A/S (GMAB) Stock Price, News, Quote & History - Yahoo Finance
Find the latest Genmab A/S (GMAB) stock quote, history, news and other vital information to help you with your stock trading and investing.
Yahoo Finance (finance.yahoo.com)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
